Abstract 5629: Modeling cyclophosphamide induced ovarian toxicity in a novel translational canine model

Abstract

Abstract Reproductive failure following chemotherapy and/or ionizing radiation is a major adverse event, for which there are no established preventive measures. In previous studies, our laboratory has documented that the selective estrogen receptor modulator, tamoxifen (TAM) is effective in both prevention and reversal of ovarian toxicity from cyclophosphamide (CTX) in rodent models. To validate the effectiveness of this approach in a more relevant model system, we have developed a canine ovarian explant tissue model system. Dogs present with many cancers spontaneously and their pathology and treatment approaches mirror those of the human cancers. Thus, canine cancers and their treatments are excellent translational models for human diseases. Furthermore, dogs share the same environment as humans and have longer life spans than rodents. Our laboratory has recently established a dog ovarian explant tissue model system using fresh ovaries collected at the time of ovariohysterectomy. In the current study, we hypothesized that ovarian toxicity induced by CTX will be reduced by co-administration of TAM. Using this system, freshly prepared ovarian cortical tissue sections are cultured in the presence of TAM and CTX. Ovarian tissue viability is assessed by primordial and primary follicle morphometry, where the number of primordial, primary and apoptotic follicles were counted in 9 sections of 1 mm3 of ovarian cortical tissue from each dog, using CTX (at 0, 1 and 10µM) concentrations combined with TAM (0 and10µM). The number and percentage of each follicle was assessed. In addition, granulosa cells proliferation is assessed using bromodeoxyuridine (BrdU) incorporation. Further, we show that, as in women, anti-mullerian hormone (AMH) can be used as an indicator of follicle reserves in the dog, thereby establishing their use as an in-vivo monitoring system to test ovarian viability in future clinical studies. This study is intended to underpin a subsequent canine clinical trial testing TAM as a countermeasure against infertility from cancer treatment in dogs. Note: This abstract was not presented at the meeting. Citation Format: Puja Basu, Rebecca Egbert, Evan Pasternak, Brian Petroff, Nucharin Songsasen. Modeling cyclophosphamide induced ovarian toxicity in a novel translational canine model [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 5629. doi:10.1158/1538-7445.AM2017-5629